Investment Insights
We partner with Hedge Funds, Private Equity houses, Venture Capital firms, Private / Angel investors, startups and entrepreneurs, providing timely and actionable research and insights that yield a competitive advantage.
From uncovering hidden investment opportunities and identifying emerging investment trends, to supporting a due-diligence process with crucial intelligence, we can provide timely and insightful recommendations for our clients.
Our insights and advisory focus on:
- Landscape analysis, including scientific and commercial due diligence
- Company / asset profiling, including addressable market size, growth drivers and expected growth, segmentation, value proposition etc.
- Decision-making opportunity / risk assessment, both for investors and their portfolio companies
- Other research and advisory, customized to our clients’ needs
We also provide fundraising services, by connecting entrepreneurs and companies who seek the all-important capital to kick-start or grow their venture with potential investors from our extensive network of contacts.
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, related to trending news from the investment space.
Want to make informed investments and capitalize on key opportunities? Let’s connect!
Reach out to info@lqventures.com to learn more about our strategic consulting and research capabilities.
November 14, 2025
Respiratory Video Recap—November 14, 2025
November 14, 2025
Respiratory Today—November 14, 2025
November 14, 2025
Lucid Diligence Brief: T-Therapeutics Series A extension to $91m
November 13, 2025
Cell and Gene Therapy Video Recap—November 13, 2025
November 13, 2025
Cell and Gene Therapy Today—November 13, 2025
November 13, 2025
Cardiovascular Today—November 13, 2025
November 13, 2025
Rare Disease Today—November 13, 2025
November 12, 2025
Immunology Today—November 12, 2025
November 12, 2025
ESMO AI 2025 Preview: What to Watch in Oncology and AI
November 12, 2025